Evidence suggests that targeting TPX2 in tumor cells could enhance genomic instability, and significant associations between TPX2 and the prognosis of tumors with genomic instability have been proposed (Gijn et al. 2019; Hsu et al. 2017). Here, TPX2 is linked to neoplasm.